Advancing Pharmacognostic Assessment through Perfused 3D Tumor Co-Cultures: Critical Insights into Drug Transport, Immune Modulation, and Resistance

Background: Perfused Three-dimensional (3D) tumor co-culture systems are increasingly recognized as valuable platforms for pharmacognostic assessment, providing microenvironmental fidelity that enhances evaluation of natural product bioactivity, drug transport, and resistance development. Conventional Two-dimensional (2D) assays lack the architectural complexity and spatial gradients that govern compound penetration, immune cell access, and microenvironment-driven therapeutic outcomes. In contrast, perfused 3D constructs integrate vascular-mimetic flow, multicellular co-cultures, and high-content imaging to model drug transport barriers, immune-tumor interactions, and clonal evolution under treatment pressure with improved physiological relevance. Materials and Methods: Recent engineering advances, including tunable hydrogels, microfluidic perfusion, bioprinting, and embedded biosensing enable depth-resolved oxygen mapping, real-time viability assessment, and multimodal profiling of phenotypic and molecular responses. Results: These innovations support more accurate prediction of drug penetration, metabolic stress, immune localization, and emergent resistance phenotypes, offering translational value for both natural product research and oncology drug development. Conclusion: This critical review outlines key technological approaches, validation strategies, and quality-control considerations required to integrate perfused 3D systems into pharmacognostic workflows, highlighting their potential to bridge mechanistic biology with clinically relevant therapeutic response modeling.